Mammalian Polyclonal Immunoglobulin G (IgG) Antibody Market Report 2026

Mammalian Polyclonal Immunoglobulin G (IgG) Antibody Market Overview

• Mammalian Polyclonal Immunoglobulin G (IgG) Antibody market size has reached to $1.41 billion in 2025 • Expected to grow to $1.96 billion in 2030 at a compound annual growth rate (CAGR) of 6.7% • Growth Driver: Animal Health Spending Driving Growth In Small Mammal And Reptile Food Market • Market Trend: Accelerating Research With Next-Generation Antibody Technologies To Streamline Discovery And Screening Processes • North America was the largest region in 2025.

What Is Covered Under Mammalian Polyclonal Immunoglobulin G (IgG) Antibody Market?

Mammalian polyclonal IgG antibody refers to a collection of immunoglobulin G antibodies produced by multiple B cells, offering diverse antigen recognition. It is used extensively in research, diagnostics, and therapeutics for providing broad-spectrum immunity that is crucial for detecting and neutralizing pathogens and antigens. The main products of mammalian polyclonal immunoglobulin G (IgG) antibodies are cardiac markers, metabolic markers, renal markers, and others. Cardiac markers refer to a category of molecules indicating heart health, commonly used in diagnostic tests to assess cardiac function and detect heart-related conditions such as myocardial infarction. The type of mammalian includes goat, rabbit, horse, mouse, and others. There are various applications such as enzyme-linked immuno absorbant assay (ELISA), immuno turbidometry, immuno electrophoresis, antibody identification, immunohistochemistry, immunocytochemistry, and western blotting for end user such as pharmaceutical and biotechnology companies, hospitals, diagnostic centers, and academic and research centers.

What Is The Mammalian Polyclonal Immunoglobulin G (IgG) Antibody Market Growth Forecast?

The mammalian polyclonal immunoglobulin g (igg) antibody market size is expected to see strong growth in the next few years. It will grow to $1.96 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to expansion of precision diagnostics, growth in biomarker-based testing, increasing pharmaceutical r&d investments, rising demand from emerging healthcare markets, continuous development of advanced immunoassay platforms. Major trends in the forecast period include growing use of polyclonal igg in diagnostic assays, rising demand for broad-spectrum antibody reagents, expansion of immunoassay-based testing applications, increased adoption in translational and preclinical research, focus on high-affinity and batch-consistent antibody production.

Global Mammalian Polyclonal Immunoglobulin G (IgG) Antibody Market Segmentation

1) By Product: Cardiac Markers, Metabolic Markers, Renal Markers, Other Products 2) By Source Animal: Goat, Rabbit, Horse, Mouse, Other Source Animals 3) By Application: Enzyme Linked Immuno Absorbent Assay (ELISA), Immunoturbidimetry, Immunoelectrophoresis, Antibody Identification, Immunohistochemistry, Immunocytochemistry, Western Blotting 4) By End User: Pharmaceutical And Biotechnology Companies, Hospitals, Diagnostic Centers, Academic And Research Centers Subsegments: 1) By Cardiac Markers: Troponin, BNP (B-Type Natriuretic Peptide), CK-MB (Creatine Kinase-MB), Myoglobin 2) By Metabolic Markers: Glucose, Lipids, Insulin, HbA1c (Glycated Hemoglobin), Cholesterol 3) By Renal Markers: Creatinine, Albumin, Urea, BUN (Blood Urea Nitrogen), Cystatin C 4) By Other Products: Infectious Disease Markers, Tumor Markers, Autoimmune Disease Markers, Hormonal Markers, Inflammation Markers

What Is The Driver Of The Mammalian Polyclonal Immunoglobulin G (IgG) Antibody Market?

The increasing spending on animal health is expected to propel the growth of the mammalian polyclonal immunoglobulin G (IgG) antibody markets going forward. Animal health refers to the holistic care and management practices aimed at ensuring the well-being and longevity of animals, including pets, livestock, and wildlife. Spending on animal health is increasing due to rising pet ownership, greater demand for animal products, advances in veterinary care, stronger human-animal bonds, and stricter regulations. Higher spending on animal health boosts demand for specialized mammalian polyclonal immunoglobulin G (IgG) antibody, spurring innovation, loyalty, vet collaboration, and market growth in the pet care sector. For instance, in March 2023, according to the American Pet Products Association, a US-based not-for-profit industry association, pet foods and treats saw the highest spending at $58.1 billion, marking a significant 16.2% increase, making it the category with the largest growth. Therefore, the increasing spending on animal health is expected to propel the growth of the mammalian polyclonal immunoglobulin G (IgG) antibody industry.

Key Players In The Global Mammalian Polyclonal Immunoglobulin G (IgG) Antibody Market

Major companies operating in the mammalian polyclonal immunoglobulin g (igg) antibody market are Thermo Fisher Scientific Inc., Merck KGaA, PerkinElmer Inc., Bio-Rad Laboratories Inc., GeneTex, GenScript Biotech Corporation, Jackson ImmunoResearch Laboratories, Abcam Inc., R&D Systems, Sino Biological, Fortis Life Sciences, OriGene Technologies, Cell Signaling Technology Inc., Cedarlane Labs, Capralogics Inc, Proteintech Group, ProSci LLC, Santa Cruz Biotechnology Inc., Rockland Immunochemicals Inc., Novus Biologicals LLC, Creative Diagnostics, Fitzgerald Industries International Inc.

Global Mammalian Polyclonal Immunoglobulin G (IgG) Antibody Market Trends and Insights

Major companies operating in the mammalian polyclonal immunoglobulin G (IgG) Antibody market are focusing on developing innovative products, such as high-throughput antibodies to accelerate research and therapeutic development. High-throughput antibodies are antibodies produced rapidly and at scale using automated workflows, helping researchers screen large numbers of targets quickly, reduce development time, and accelerate therapeutic discovery. For instance, in July 2024, Twist Bioscience Corporation, a US-based synthetic biology and genomics company, launched Twist Express Antibodies, CHO, an innovative technology designed to streamline antibody development. These antibodies are generated from user-defined sequences using Twist’s silicon-based DNA synthesis platform, cloned into IgG scaffold vectors, and produced in CHO cells with turnaround times starting at 13 business days. Each antibody batch includes yield data for screening and quality assurance, making the process cost-effective, customizable, and suitable for high-throughput candidate selection. The antibodies are applicable in biotherapeutic drug discovery, research screening, and experimental validation, providing a robust and efficient alternative to traditional lab-based antibody synthesis.

What Are Latest Mergers And Acquisitions In The Mammalian Polyclonal Immunoglobulin G (IgG) Antibody Market?

In December 2023, Danaher Corporation, a US-based life sciences and diagnostics innovator, acquired Abcam Limited for an undisclosed amount. The acquisition was aimed to enhance Danaher's capabilities and expand its market presence, benefiting both the company and its shareholders. Abcam Limited is a US-based producer, distributor, and seller of protein research tools, including rabbit polyclonal GFAP antibodies.

Regional Outlook

North America was the largest region in the mammalian polyclonal immunoglobulin G (IgG) antibody market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Mammalian Polyclonal Immunoglobulin G (IgG) Antibody Market?

The mammalian polyclonal IgG antibody market consists of sales of infectious disease markers, autoimmune disease markers, tumor markers, and inflammatory markers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Mammalian Polyclonal Immunoglobulin G (IgG) Antibody Market Report 2026?

The mammalian polyclonal immunoglobulin g (igg) antibody market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the mammalian polyclonal immunoglobulin g (igg) antibody industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.